pubmed· e01.org

PubMed · PMID 28762012

Cross-cultural comparison of breast cancer patients' Quality of Life in the Netherlands and Japan.

PMID 28762012Journal Breast cancer research and treatmentYear 2017Authors 16DOI 10.1007/s10549-017-4417-z

  • Source PubMed
  • Journal Breast cancer research and treatment
  • Year 2017
  • Authors M J Fischer; K Inoue; A Matsuda; J R Kroep; S Nagai; K Tozuka; M Momiyama; N I Weijl; D Langemeijer-Bosman; S R S Ramai; J W R Nortier; H Putter; K Yamaoka; K Kubota; K Kobayashi; A A Kaptein
  • Licence NLM/PubMed terms

Abstract

Cultural differences are hypothesized to influence patients' Quality of Life (QoL) reports. However, there is a lack of empirical cross-cultural studies comparing QoL of patients with cancer. This study aims to compare QoL of women with breast cancer in the Netherlands and Japan, and to investigate the association of QoL with sociodemographic, clinical, and psychological variables (illness perceptions).

Dutch (n = 116) and Japanese (n = 148) women with early breast cancer undergoing chemotherapy completed the EORTC QLQ-C30 and Brief Illness Perception Questionnaire immediately before their second cycle of chemotherapy. Dutch women reported poorer Physical, Role, Emotional, and Cognitive functioning than Japanese women. Additionally, illness perceptions were significantly different in Japan and the Netherlands, but these did not vary across treatment type.

In Japan, QoL of women receiving AC-chemotherapy was better than that of women receiving FEC-chemotherapy, whereas in the Netherlands, QoL did not vary as a function of chemotherapy. Illness perceptions about symptom severity, adverse consequences, and emotional representations were negatively related to most domains of patients' QoL in both countries. Adding illness perceptions as covariates to the ANOVA analyses rendered the effects of country and treatment type on QoL non-significant.

Comparing Dutch and Japanese women with early breast cancer revealed important differences in treatment modalities and illness perceptions which both appear to influence QoL. Perceptions about cancer have been found to vary across cultures, and our study suggests that these perceptions should be considered when performing cross-cultural studies focusing on patient-reported outcomes.

Record details

PMID28762012
PMCIDnot held
DOI10.1007/s10549-017-4417-z
JournalBreast cancer research and treatment
Year2017
AuthorsM J Fischer; K Inoue; A Matsuda; J R Kroep; S Nagai; K Tozuka; M Momiyama; N I Weijl; D Langemeijer-Bosman; S R S Ramai; J W R Nortier; H Putter; K Yamaoka; K Kubota; K Kobayashi; A A Kaptein
Licencenot stated
MeSHAdult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cross-Cultural Comparison; Drug Therapy; Female; Humans; Japan; Middle Aged; Netherlands; Quality of Life; Treatment Outcome

Source record

Open the PubMed record. This page holds the abstract and citation fields for this PMID; no PMC full text is held for it.

Source
PubMed / NLM
PMID
28762012
Rendered
2026-11-21
Completeness
abstract and citation fields